Ezetimibe added to ongoing statin therapy:: Incremental reductions in low-density lipoprotein cholesterol are independent of statin efficacy

被引：0
|
作者：
Mata, P
Roth, E
Masana, L
Pintó, X
Troxell, J
Allen, C
Gumbiner, B
机构：
[1] Hosp San Joan, Reus, Spain
[2] Fdn Jimenez Diaz, Madrid, Spain
[3] Ciutat Sanitaria 1 Univ Bellvitge, Barcelona, Spain
[4] Sterling Res Grp, Cincinnati, OH USA
[5] Merck & Co Inc, Rahway, NJ 07065 USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2004年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：135 / 135
页数：1
相关论文
共 50 条
  • [1] Addition of ezetimibe to ongoing statin therapy: incremental reduction in low-density lipoprotein cholesterol is independent of statin type
    Mata, P
    Gumbiner, B
    Musliner, T
    Quinto, K
    Cho, M
    EUROPEAN HEART JOURNAL, 2002, 23 : 19 - 19
  • [2] Getting there: Statin plus ezetimibe for low-density lipoprotein cholesterol
    Hurley, DL
    Isley, WL
    MAYO CLINIC PROCEEDINGS, 2005, 80 (05) : 585 - 586
  • [3] Statin therapy and reductions in low-density lipoprotein cholesterol: Initial clinical data on the potent new statin rosuvastatin
    Olsson, AG
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (5A): : 33B - 36B
  • [4] Statin and ezetimibe combination therapy: New therapeutic options for lowering Low-Density Lipoprotein Cholesterol
    Lin, Xiao-Long
    Liu, Mi-Hua
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 247 : 49 - 49
  • [5] Effectiveness of ezetimibe added to ongoing statin therapy in modifying lipid profiles and low-density lipoprotein cholesterol goal attainment in patients of different races and ethnicities: A substudy of the ezetimibe add-on to statin for effectiveness trial
    Pearson, Thomas A.
    Denke, Margo A.
    McBride, Patrick E.
    Battisti, Wendy P.
    Gazzara, Russell A.
    Brady, William E.
    Palmisano, Joanne
    MAYO CLINIC PROCEEDINGS, 2006, 81 (09) : 1177 - 1185
  • [6] Effect of Ezetimibe Added to High-Intensity Statin Therapy on Low-Density Lipoprotein Cholesterol Levels: A Meta-Analysis
    Lee, Jayden
    Egolum, Ugochukwu
    Parihar, Harish
    Cooley, Michael
    Ling, Hua
    CARDIOLOGY RESEARCH, 2021, 12 (02) : 98 - 108
  • [7] Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT
    Oyama, Kazuma
    Giugliano, Robert P.
    Blazing, Michael A.
    Park, Jeong-Gun
    Tershakovec, Andrew M.
    Sabatine, Marc S.
    Cannon, Christopher P.
    Braunwald, Eugene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (15) : 1499 - 1507
  • [8] Low-density lipoprotein cholesterol reduction with immediate combination therapy of statin and ezetimibe compared to statin monotherapy after percutaneous coronary intervention
    Burger, Achim Leo
    Beran, Nora
    Pogran, Edita
    Kaufmann, Christoph C.
    Zweiker, David
    Muthspiel, Marie
    Panzer, Benjamin
    Jaeger, Bernhard
    Rohla, Miklos
    Huber, Kurt
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (23-24) : 674 - 679
  • [9] Low-density lipoprotein cholesterol reduction with immediate combination therapy of statin and ezetimibe compared to statin monotherapy after percutaneous coronary intervention
    Achim Leo Burger
    Nora Beran
    Edita Pogran
    Christoph C. Kaufmann
    David Zweiker
    Marie Muthspiel
    Benjamin Panzer
    Bernhard Jäger
    Miklos Rohla
    Kurt Huber
    Wiener klinische Wochenschrift, 2023, 135 : 674 - 679
  • [10] Initial low-density, lipoprotein response to statin therapy predicts subsequent low-density lipoprotein response to the addition of Ezetimibe
    Ziajka, PE
    Reis, M
    Kreul, S
    King, H
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (06): : 779 - 780
12345